(Total Views: 63)
Posted On: 03/12/2019 11:09:44 AM
Post# of 44029

$RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease
https://finance.yahoo.com/news/regen-biopharm...00199.html
https://finance.yahoo.com/news/regen-biopharm...00199.html

